Fulvio Magni researcher
Magni, Fulvio, 1957-
Magni, Fulvio
VIAF ID: 12150686587112542327 (Personal)
Permalink: http://viaf.org/viaf/12150686587112542327
Preferred Forms
- 100 0 _ ‡a Fulvio Magni ‡c researcher
- 100 1 _ ‡a Magni, Fulvio
- 100 1 _ ‡a Magni, Fulvio ‡d 1957-
- 100 1 _ ‡a Magni, Fulvio ‡d 1957-
- 100 1 _ ‡a Magni, Fulvio, ‡d 1957-
4xx's: Alternate Name Forms (3)
5xx's: Related Names (3)
- 551 _ _ ‡a Mailand ‡4 ortw ‡4 https://d-nb.info/standards/elementset/gnd#placeOfActivity
- 510 2 _ ‡a Università degli studi di Milano-Bicocca ‡4 affi ‡4 https://d-nb.info/standards/elementset/gnd#affiliation ‡e Affiliation
- 551 _ _ ‡a Verano, Brianza ‡4 ortg ‡4 https://d-nb.info/standards/elementset/gnd#placeOfBirth
Works
Title | Sources |
---|---|
[11C]RN5: a new agent for the in vivo imaging of myocardial alpha1-adrenoceptors | |
Diabetes-induced alteration of HMGCoA reductase forms in rat livers | |
Different expression of Fibrinopeptide A and related fragments in serum of type 1 diabetic patients with nephropathy | |
Effects of an acute increase in plasma triglyceride levels on glucose metabolism in man | |
Enhancement of tumor necrosis factor alpha antitumor immunotherapeutic properties by targeted delivery to aminopeptidase N (CD13). | |
Evolution of Nanoparticle Protein Corona across the Blood-Brain Barrier | |
Expanding the proteome two-dimensional gel electrophoresis reference map of human renal cortex by peptide mass fingerprinting. | |
Experimental validation of the complement protein C3a down expression in the plasma of patients with squamous cell carcinoma of the penis. | |
Flunoxaprofen, a new non-steroidal anti-inflammatory drug, does not interfere with prostaglandin synthesis in rat gastric mucosa | |
Functional and Immunological Analysis of Recombinant Mouse H- and L-Ferritins from Escherichia coli | |
Gluconeogenesis in isolated rat hepatocytes evaluated by gas chromatography/mass spectrometry using deuterated water | |
Glucose turnover and insulin clearance after growth hormone treatment in girls with Turner's syndrome. | |
Histology-guided proteomic analysis to investigate the molecular profiles of clear cell Renal Cell Carcinoma grades | |
Histoproteomic Characterization of Localized Cutaneous Amyloidosis in X-Linked Reticulate Pigmentary Disorder | |
Hydrolysis of cyclosporin A: identification of 1,11 seco-cyclosporin A and 4,5 seco-isocyclosporin A by FAB-MS/MS. | |
A hyphenated microLC-Q-TOF-MS platform for exosomal lipidomics investigations: application to RCC urinary exosomes. | |
Identification of Sulfonylureas in Serum by Electrospray Mass Spectrometry | |
Imaging mass spectrometry: a new tool for kidney disease investigations. | |
Implementation of proteomic biomarkers: making it work | |
Improved synthesis and radiolabeling of [11C]MP4A, a suitable ligand for the investigation of the cholinergic system using PET. | |
Increased susceptibility to plasma lipid peroxidation in Alzheimer disease patients | |
Insulin regulation of glucose turnover and lipid levels in obese children with fasting normoinsulinaemia. | |
Insulin resistance and endothelial function are improved after folate and vitamin B12 therapy in patients with metabolic syndrome: relationship between homocysteine levels and hyperinsulinemia | |
Integration of omics approaches and systems biology for clinical applications | |
Intracerebral hemorrhage in intensive care unit: early prognostication fallacies. A single center retrospective study. | |
Intraluminal proteome and peptidome of human urinary extracellular vesicles | |
Long-term oral L-arginine administration improves peripheral and hepatic insulin sensitivity in type 2 diabetic patients | |
Machine learning approaches in MALDI-MSI: clinical applications | |
MALDI-MSI Analysis of Cytological Smears: The Study of Thyroid Cancer. | |
MALDI-MSI Pilot Study Highlights Glomerular Deposits of Macrophage Migration Inhibitory Factor | |
Mediation of the hepatic effects of growth hormone by its lipolytic activity | |
Modulation of urinary peptidome in humans exposed to high altitude hypoxia | |
Molecular signatures of medullary thyroid carcinoma by matrix-assisted laser desorption/ionisation mass spectrometry imaging. | |
Mutations of the CK2 phosphorylation site of Sic1 affect cell size and S-Cdk kinase activity in Saccharomyces cerevisiae. | |
Mutual information optimization for mass spectra data alignment | |
Non-invasively collected amniotic fluid as a source of possible biomarkers for premature rupture of membranes investigated by proteomic approach. | |
Novel domain-selective ACE-inhibiting activity of synthetic growth hormone secretagogues. | |
Open-chain peptides obtained by acidic hydrolytic cleavage of cyclosporin A. | |
The PAF-acether receptor antagonist BN-52021 inhibits mediator release during guinea-pig active lung anaphylaxis | |
Palmitic is the main fatty acid carried by lipids of detergent-resistant membrane fractions from neural and non-neural cells. | |
Pharmacological activity of bamifylline on lung anaphylaxis: in vitro studies | |
Platelet formation of 12-hydroxyeicosatetraenoic acid and thromboxane B2 is increased in type IIA hypercholesterolemic subjects | |
Prevention of antigen-induced early obstructive reaction by inhaled furosemide in (atopic) subjects with asthma and (actively sensitized) guinea pigs | |
Production and Biologic Interactions of Prostacyclin and Platelet-Activating Factor in Acute Myocardial Ischemia in the Perfused Rabbit Heart | |
Protein profiling of microdomains purified from renal cell carcinoma and normal kidney tissue samples | |
Proteomic analysis in clear cell renal cell carcinoma: identification of differentially expressed protein by 2-D DIGE. | |
Proteomic analysis of a nutritional shift-up in Saccharomyces cerevisiae identifies Gvp36 as a BAR-containing protein involved in vesicular traffic and nutritional adaptation. | |
Proteomic and Bioinformatic Studies for the Characterization of Response to Pemetrexed in Platinum Drug Resistant Ovarian Cancer. | |
Proteomic knowledge of human aquaporins. | |
The proteomic landscape of renal tumors. | |
Proteomic profiles of thyroid tumors by mass spectrometry-imaging on tissue microarrays. | |
Proteomics for the diagnosis of thyroid lesions: preliminary report | |
Proteomics in thyroid cytopathology: Relevance of MALDI-imaging in distinguishing malignant from benign lesions | |
Proteomics of liquid biopsies: Depicting RCC infiltration into the renal vein by MS analysis of urine and plasma. | |
The putative role of MALDI-MSI in the study of Membranous Nephropathy. | |
Quantitation of cyclosporin A in whole blood by liquid chromatography/stable isotope dilution electrospray ionization mass spectrometry | |
Respiratory metabolism and calorie restriction relieve persistent endoplasmic reticulum stress induced by calcium shortage in yeast | |
Serum Biomarkers of Renal Cell Carcinoma Assessed Using a Protein Profiling Approach Based on ClinProt Technique | |
Simultaneous determination of plasma levels of alpha-ketoisocaproic acid and leucine and evaluation of alpha-[1-13C]ketoisocaproic acid and [1-13C]leucine enrichment by gas chromatography-mass spectrometry | |
Stimulus-related difference in the formation of leukotrienes and PGD2 after immunological and non-immunological challenge of human lung parenchyma “in vitro” | |
Structure-activity relationships of chromogranin A in cell adhesion. Identification of an adhesion site for fibroblasts and smooth muscle cells | |
A Support Vector Machine Classification of Thyroid Bioptic Specimens Using MALDI-MSI Data | |
Synthesis and carbon-11 labeling of (R)- and (S)-thionisoxetine, norepinephrine reuptake inhibitors, potential radioligands for positron emission tomography | |
Synthesis and in vivo evaluation of [11C]CGP62349, a new GABAB receptor antagonist | |
Synthesis of [O-methyl-11C]fluvoxamine--a potential serotonin uptake site radioligand. | |
Targeted delivery of IFNgamma to tumor vessels uncouples antitumor from counterregulatory mechanisms | |
Towards the standardization of mitochondrial proteomics: the Italian mt-HPP initiative | |
Tumor size, stage and grade alterations of urinary peptidome in RCC. | |
Urinary exosomes and diabetic nephropathy: a proteomic approach. | |
Urinary peptide biomarker panel associated with an improvement in estimated glomerular filtration rate in chronic kidney disease patients. | |
The urinary proteome and peptidome of renal cell carcinoma patients: a comparison of different techniques | |
Urinary proteomics for the study of genetic kidney diseases | |
Urinary signatures of Renal Cell Carcinoma investigated by peptidomic approaches. | |
Validation of malondialdehyde and 4-hydroxy-2-trans-nonenal measurement in plasma by NICI-GC-MS. | |
α-1-Antitrypsin detected by MALDI imaging in the study of glomerulonephritis: Its relevance in chronic kidney disease progression. |